Cargando…
Development of Technetium-99m-Labeled BODIPY-Based Probes Targeting Lipid Droplets Toward the Diagnosis of Hyperlipidemia-Related Diseases
Hyperlipidemia causes systemic lipid disorder, which leads to hepatic steatosis and atherosclerosis. Thus, it is necessary to detect these syndromes early and precisely to improve prognosis. In the affected regions, abnormal formation and growth of lipid droplets is observed; therefore, lipid drople...
Autores principales: | Shimizu, Yoichi, Tanimura, Keiichi, Iikuni, Shimpei, Watanabe, Hiroyuki, Saji, Hideo, Ono, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631856/ https://www.ncbi.nlm.nih.gov/pubmed/31248199 http://dx.doi.org/10.3390/molecules24122283 |
Ejemplares similares
-
Development of a hydroxamamide-based bifunctional chelating agent to prepare technetium-99m-labeled bivalent ligand probes
por: Shimizu, Yoichi, et al.
Publicado: (2021) -
Cancer radiotheranostics targeting carbonic anhydrase-IX with (111)In- and (90)Y-labeled ureidosulfonamide scaffold for SPECT imaging and radionuclide-based therapy
por: Iikuni, Shimpei, et al.
Publicado: (2018) -
Novel Bivalent (99m)Tc-Complex with N-Methyl-Substituted Hydroxamamide as Probe for Imaging of Cerebral Amyloid Angiopathy
por: Iikuni, Shimpei, et al.
Publicado: (2016) -
Imaging of Cerebral Amyloid Angiopathy with Bivalent (99m)Tc-Hydroxamamide Complexes
por: Iikuni, Shimpei, et al.
Publicado: (2016) -
Radioiodination of BODIPY and its application to a nuclear and optical dual functional labeling agent for proteins and peptides
por: Ono, Masahiro, et al.
Publicado: (2017)